Navigation Links
Drug Meant to Heal Turns ‘heel’ and Hars

In a case of a therapeutic drug turning deadly, hundred of persons have been infected with Hepatitis C.//

Chinese officials from the ministry of heath have ordered the recall of samples of the blood-based drug used in the treatment of immune system deficiencies.

The drug manufactured by Guangdong Bioyee Pharmaceutical Co. Ltd., is extracted from human blood and injected intravenously during treatment.

China's Health Ministry and drug watchdog, the State Food and Drug Administration, said that the Guangdong Bioyee Pharmaceutical Co. Ltd. had committed "illegal behavior" in the production of its immunoglobulin drug and that users had tested positive to "Hepatitis C antibodies".

Officials have recalled around 90,000 doses of the drug and ordered the cessation of its production and sale.

Hepatitis C can lead to chronic liver infection and cirrhosis. About 1 percent to 5 percent of people with the disease eventually die from long-term infection, according to the U.S. Centers for Disease Control and Prevention.

The Health News, a newspaper run by China's Health Ministry, quoted experts as saying that the plasma used to make the immunoglobulin drug might have contained either the hepatitis C virus or its antibodies.

It would take two to eight weeks to rule out the chance of hepatitis C infections for the users, the newspaper said.

The reports did not say how many users the drug had affected or how many samples of the drug were problematic.

Doctor Jia Jidong, from Beijing Friendship Hospital, says not everyone with hepatitis C antibodies in their blood have will fall ill with the diseases.

He estimates that about 50 to 85 percent of those tested positive for antibodies will end up contracting the disease and it can take up to eight weeks before symptoms appear.

Fake or tainted drugs have killed dozens in China in recent years and sparked public fury about drug safety.

The Chinese media puts the blame on businesses chasing profits and on complacent official supervision.


ANN
'"/>




Related medicine news :

1. An Enzyme That Turns a One –time Experience into a long-time Memor
2. Daughter Turns Saviour: Ailing Mother Provided Wonder Drug Herceptin, To Fight Cancer
3. Allergy Alarm: Sams Choice Milk Chocolate Turns Bitter with Undisclosed Nuts
4. Where Mothers Skin Turns Into Food For Offspring
5. A Worm Turns: Banking on Blood From a Little Lugworm
6. Toy Story Turns Bitter-Christmas Toys, No Music to the Ears!
7. Leukemia Drug Turns Mini-Molecules Up, Cancer Genes Down
8. Well-known Kerala Actor, Mohanlal, Turns AIDS Activist
9. Fashion Fraternity Turns Socially Conscious
10. Friend’s Love Turns Out to Be Gay Admiratio
11. Super Bug Turns Super Killer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/18/2017)... ... 2017 , ... MLM Insurance Group, a Miami area provider ... is working to support the Take Stock In Children Foundation during a regional ... The Take Stock In Children Foundation (TSC) offers guidance and assistance to low ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... of highly trained practitioners specializing in bioidentical hormone replacement therapy and integrative medicine, ... hormone imbalance and conditions of aging, such as menopause, andropause, thyroid disorder and ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Our Mountains to Climb: ... of a couple that grew stronger together through the faith they shared to overcome ... Trials” is the creation of published author, Barbara J. Corcoran, a retired teacher and ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin Care Ltd., ... solutions, recently announced the launch of two new skincare products, Prache Antiaging ... alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , “We are ...
(Date:8/17/2017)... ... 17, 2017 , ... Riccobene Associates Family Dentistry, the Research ... to its family of practices. Residents of Goldsboro will be able to experience ... , Riccobene Associates Family Dentistry, founded by Dr. Michael Riccobene in 2000, ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... International plc (NASDAQ: ENDP ) today announced that ... U.S. mesh product liability claims and that it is ... claims at reasonable values. Under the agreements, Endo will ... 2017 and continuing through the fourth quarter of 2019. ... Company intends to increase its mesh product liability accrual ...
(Date:8/2/2017)... 2, 2017 Fenita J. Caldwell ... a Pinnacle Lifetime Professional in the Field of ... at Turing Pharmaceuticals, AG. Her skills and areas ... building.                ... years of experience as a highly successful sales ...
(Date:8/1/2017)... --  CerSci Therapeutics , a non-opioid drug development firm ... received notice from the National Institute on Drug Abuse ... it has been awarded a Direct-to-Phase II Small Business ... with an additional $1,000,000 to follow in 2018. These ... their lead non-opioid drug candidate CT-044 to the Food ...
Breaking Medicine Technology: